COMBINATION THERAPY FOR TREATING CANCER WITH A RECOMBINANT POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN IMMUNE CHECKPOINT MOLECULE ANTAGONIST OR AGONIST
- 专利权人:
- 버베리안 노딕 에이/에스
- 发明人:
- 포이, 수잔,만들, 스테파니,라운트리, 라이언,프란즈소프, 알렉스
- 申请号：
- KR1020167030977
- 公开号：
- KR1020170003556A
- 申请日:
- 2015.05.08
- 申请国别(地区):
- KR
- 年份:
- 2017
- 代理人:
- 摘要：
- The present invention relates to compositions, kits and methods for cancer therapy using recombinant poxvirus encoding antigen-associated antigens in conjunction with antagonists or agonists of immune checkpoint inhibitors.본 발명은 면역 체크포인트 저해제의 길항제 또는 효현제와 합동으로 종양-연관된 항원을 인코딩하는 재조합 폭스바이러스를 이용한 암 요법을 위한 조성물, 키트 및 방법에 관계한다.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Combination therapy for treating cancer with a recombinant poxvirus expressing a tumor antigen and an immune checkpoint molecule antagonist or agonist
- Combination therapy for treating cancer with a recombinant poxvirus expressing a tumor antigen and an immune checkpoint molecule antagonist or agonist
- Combination therapy for cancer treatment using tumor antigen expressing recombinant poxvirus and immune checkpoint molecule antagonist or agonist
- Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor
- Combination therapy for treating cancer with a poxvirus expressing a tumor antigen and an antagonist and/or agonist of an immune checkpoint inhibitor
